Nausea and Vomiting Treatment Guidelines
Introduction to Nausea and Vomiting Management
- The National Comprehensive Cancer Network recommends a stepwise approach for treating nausea and vomiting, starting with dopamine receptor antagonists (such as metoclopramide) as first-line therapy for non-specific nausea and vomiting, followed by 5-HT3 receptor antagonists (such as ondansetron) for persistent symptoms 1, 2
- The American Society of Clinical Oncology suggests that metoclopramide has the strongest evidence for non-chemotherapy related nausea 2
Initial Assessment and Identification of Cause
- Potential causes of nausea and vomiting include medication side effects (opioids, antibiotics, antifungals) 3, 4, gastrointestinal disorders (gastritis, reflux, obstruction) 1, 5, metabolic disorders (hypercalcemia, electrolyte disturbances) 3, 4, chemotherapy or radiation therapy 6, 7, and psychological factors (anxiety) 1
First-Line Treatment Options
- For non-specific nausea and vomiting, dopamine receptor antagonists (prochlorperazine, haloperidol, metoclopramide, olanzapine) are recommended 1, 5
- Benzodiazepines can be effective for anxiety-related nausea 1, 5
- Proton pump inhibitors or H2 receptor antagonists are recommended for gastritis or gastroesophageal reflux 1, 5
Treatment for Persistent Nausea and Vomiting
- Adding 5-HT3 receptor antagonists (ondansetron) is recommended for persistent symptoms 1, 5
- Consider adding anticholinergic agents and/or antihistamines 1, 5
- Corticosteroids (dexamethasone) can be added for refractory symptoms 1, 5
- Continuous or subcutaneous infusion of antiemetics may be considered for severe symptoms 1, 5
Special Considerations
- For highly emetogenic chemotherapy, a combination of 5-HT3 receptor antagonist, dexamethasone, and NK1 receptor antagonist is recommended 6, 7
- For moderately emetogenic chemotherapy, a combination of 5-HT3 receptor antagonist and dexamethasone is recommended 6, 7
- Administering prophylactic antiemetics 30-60 minutes before chemotherapy is suggested 3, 4
- Octreotide has shown efficacy in randomized controlled trials for inoperable bowel obstruction 8
- Surgical intervention is recommended for patients with bowel obstruction and good performance status 8, 2
Non-Pharmacologic Approaches
- Alternative therapies such as acupuncture, hypnosis, or cognitive behavioral therapy may be beneficial 1, 5
Treatment Algorithm
- The treatment algorithm involves identifying and treating the underlying cause, starting with dopamine receptor antagonists, and adding or switching to 5-HT3 receptor antagonists for persistent symptoms 5, 7
- Combination therapy with multiple agents targeting different receptors may be considered for refractory symptoms 7
- Specialized palliative care consultation may be necessary for severe cases unresponsive to standard therapy 1, 5